US Patent 9822173 Heterodimeric immunoglobulins
Patent 9822173 was granted and assigned to Amgen on November, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+98 characters)
Article
Patent abstract
The present application is directed to heterodimeric antibodies and methods of use.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Gunasekaran Kannan0
Monica Florio0
Wei Yan0
Zhi Liu0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09822173 Heterodimeric immunoglobulins US Patent 9822173 Heterodimeric immunoglobulins
Infobox
Patent Number
098221730
Patent Number
98221730
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
098221730
Date of Patent
November 21, 2017
0Patent Application Number
144431070
Date Filed
November 21, 2013
0Patent Primary Examiner
Edits on 15 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09822173 Heterodimeric immunoglobulins
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09822173
Date of patent
November 21, 2017
Patent application number
14443107
Date Filed
November 21, 2013
Patent primary examiner
Find more entities like US Patent 9822173 Heterodimeric immunoglobulins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.